Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination

Ítems similars

• Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms
  per: Baird, J. Kevin, et al.
  Publicat: (2018)
• G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
  per: Han, Kay Thwe, et al.
  Publicat: (2021)
• G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
  per: Sara Avalos, et al.
  Publicat: (2018-11-01)
• G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
  per: Avalos, Sara, et al.
  Publicat: (2018)
• On the relation between malaria and G-6-PD deficiency
  per: Bottini, E., et al.
  Publicat: (1978)